Enanta Pharmaceuticals Ownership | Who Owns Enanta Pharmaceuticals?
Enanta Pharmaceuticals Ownership Summary
Enanta Pharmaceuticals is owned by 85.95% institutional investors, 6.55% insiders, and 7.49% retail investors. Farallon capital management is the largest institutional shareholder, holding 9.95% of ENTA shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.95% of its assets in Enanta Pharmaceuticals shares.
ENTA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Enanta Pharmaceuticals | 85.95% | 6.55% | 7.49% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Farallon capital management | 2.12M | 9.95% | $16.04M |
| Krensavage asset management | 2.11M | 9.92% | $15.98M |
| Vanguard group | 1.98M | 9.38% | $11.41M |
| Blackrock | 1.85M | 8.72% | $23.96M |
| Blackrock funding, inc. /de | 1.85M | 8.66% | $13.96M |
| Morgan stanley | 1.46M | 6.88% | $18.89M |
| Millennium management | 1.35M | 6.33% | $7.44M |
| Acadian asset management | 867.04K | 4.07% | $6.55M |
| Marshall wace, llp | 857.41K | 4.02% | $6.48M |
| Northern trust | 845.12K | 3.99% | $10.96M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Krensavage asset management | 2.11M | 8.46% | $15.98M |
| Stonepine capital management | 604.07K | 4.48% | $4.57M |
| Sio capital management | 178.77K | 0.52% | $1.35M |
| Farallon capital management | 2.12M | 0.07% | $16.04M |
| Tang capital management | 126.66K | 0.05% | $957.51K |
| Skopos labs | 42.51K | 0.04% | $321.41K |
| Sherbrooke park advisers | 12.54K | 0.04% | $94.79K |
| Pdt partners | 86.75K | 0.04% | $655.85K |
| Portland global advisors | 33.19K | 0.03% | $250.88K |
| Quest partners | 22.26K | 0.02% | $128.00K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Millennium management | 1.35M | 0.00% | 449.94K |
| Dimensional fund advisors lp | 297.11K | 0.00% | 102.65K |
| Bank of america corp /de/ | 595.91K | 0.00% | 79.55K |
| Trexquant investment lp | 135.95K | 0.01% | 67.04K |
| Skopos labs | 42.51K | 0.04% | 42.51K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -1.04M |
| Armistice capital | - | - | -1.00M |
| Soleus capital management | - | - | -785.55K |
| Morgan stanley | 1.46M | 0.00% | -588.59K |
| Ameriprise financial | 70.43K | 0.00% | -257.88K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Skopos labs | 42.51K | 0.04% | 42.51K | $321.41K |
| Norges bank | 40.70K | - | 40.70K | $234.03K |
| Bank of montreal /can/ | 31.75K | 0.00% | 31.75K | $182.55K |
| Susquehanna group, llp | 12.22K | - | 12.22K | $70.24K |
| China universal asset management | 4.49K | 0.00% | 4.49K | $25.84K |
Sold Out
| Holder | Change |
|---|---|
| Ifp advisors | -3.00 |
| Nelson, van denburg & campbell wealth management group | -4.00 |
| Innealta capital | -16.00 |
| Voisard asset management group | -28.00 |
| Quadrant capital group | -35.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 104 | -5.45% | 18,326,590 | -1.61% | 85 | 1.12% | 47 | -16.07% | 41 | 10.81% |
| Mar 31, 2025 | 5 | -95.33% | 2,149,611 | -88.86% | 10 | 0.12% | 2 | -96.61% | 1 | -96.55% |
| Dec 31, 2024 | 32 | -71.17% | 5,786,937 | -72.69% | 27 | 0.27% | 17 | -69.09% | 9 | -71.88% |
| Sep 30, 2024 | 111 | 11.00% | 21,189,162 | -3.74% | 100 | 0.93% | 56 | 27.27% | 32 | -27.27% |
| Jun 30, 2024 | 100 | -6.54% | 22,011,926 | -1.25% | 103 | 0.94% | 44 | 4.76% | 44 | -12.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 629.60K | 2.95% | - |
| Vanguard Total Stock Mkt Idx Inv | 616.01K | 2.88% | -13.59K |
| iShares Russell 2000 ETF | 465.33K | 2.18% | -8.82K |
| Vanguard Strategic Small-Cap Equity Inv | 338.10K | 1.58% | - |
| Columbia Small Cap Value I A | 271.73K | 1.28% | 3.30K |
| Vanguard Institutional Extnd Mkt Idx Tr | 209.15K | 0.98% | -85.80K |
| Vanguard VIF Small Co Gr | 206.07K | 0.96% | - |
| Fidelity Small Cap Index | 204.13K | 0.95% | -4.23K |
| Columbia Small Cap Value I | 200.68K | 0.95% | 200.68K |
| Vanguard Strategic Equity Inv | 180.74K | 0.85% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 12, 2025 | Luly Jay R. | President and CEO | Buy | $256.05K |
| Dec 06, 2024 | Kieffer Tara Lynn | Chief Product Strategy Officer | Sell | $18.40K |
| Dec 06, 2024 | Luu Brendan | Chief Business Officer | Sell | $18.40K |
| Dec 06, 2024 | Rottinghaus Scott T. | Chief Medical Officer | Sell | $6.98K |
| Dec 06, 2024 | Or Yat Sun | Chief Scientific Officer | Sell | $20.88K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | - |
| 2025 Q1 | 1 | - |
| 2024 Q4 | - | 6 |
| 2024 Q3 | - | 3 |
| 2024 Q2 | - | 1 |
ENTA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools